BRIEF published on 04/23/2026 at 14:05, 3 months 27 days ago Immunic, Inc. annonce un regroupement d'actions à raison de 1 pour 10 Immunic Inc. Regroupement D'actions Inversé Assemblée Générale Des Actionnaires Réduction Des Parts Nasdaq IMUX
BRIEF published on 04/23/2026 at 14:05, 3 months 27 days ago Immunic, Inc. Announces 1-for-10 Reverse Stock Split Reverse Stock Split Immunic Inc. Stockholder Meeting Share Reduction Nasdaq IMUX
PRESS RELEASE published on 04/23/2026 at 14:00, 3 months 27 days ago Immunic, Inc. Announces 1-for-10 Reverse Stock Split Immunic, Inc. announces a 1-for-10 reverse stock split to meet contractual obligations, reducing outstanding shares from 136M to 13.6M Shareholders Reverse Stock Split Nasdaq Immunic Inc. Neurologic Diseases
BRIEF published on 04/09/2026 at 12:35, 4 months 12 days ago Immunic to Engage in Key Scientific Conferences in April Biotechnology Clinical Trials Conférences Oral Therapies Neurology
BRIEF published on 04/09/2026 at 12:35, 4 months 12 days ago Immunic participera à des conférences scientifiques majeures en avril Biotechnologie Conférences Essais Cliniques Thérapies Orales Neurologie
PRESS RELEASE published on 04/09/2026 at 12:30, 4 months 12 days ago Immunic to Participate in Scientific and Medical Conferences in April Immunic, Inc. to participate in scientific and medical conferences in April. Presentation on vidofludimus calcium for treating multiple sclerosis at the Neuroimmunology Drug Development Summit and AAN Annual Meeting Immunic Inc. Multiple Sclerosis Vidofludimus Calcium Scientific Conferences Medical Conferences
BRIEF published on 04/01/2026 at 12:35, 4 months 20 days ago Immunic Achieves Nasdaq Compliance Biotechnology Nasdaq Compliance Stock Market Immunic Neurologic Therapies
BRIEF published on 04/01/2026 at 12:35, 4 months 20 days ago Immunic obtient la conformité au Nasdaq Biotechnologie Marché Boursier Immunitaire Conformité NASDAQ Thérapies Neurologiques
PRESS RELEASE published on 04/01/2026 at 12:30, 4 months 20 days ago Immunic Regains Compliance with Nasdaq Minimum Bid Price Requirement Immunic regains compliance with Nasdaq minimum bid price requirement. The company's common stock closed at $1.00 per share or greater for 20 consecutive business days Compliance Nasdaq Immunic Minimum Bid Price Neurologic Diseases
BRIEF published on 03/31/2026 at 12:35, 4 months 21 days ago Immunic Appoints Jon Congleton to Board of Directors Board Of Directors Biopharmaceutical Multiple Sclerosis Immunic Jon Congleton
Published on 08/21/2026 at 13:30, 20 minutes ago BULGOLD Announces Filing Of Financial Results For the Six Months Ended June 30, 2026
Published on 08/21/2026 at 02:30, 11 hours 20 minutes ago PPX Mining Announces Completion of Debt Settlement
Published on 08/21/2026 at 00:00, 13 hours 50 minutes ago Apex Confirms Favourable Monazite and Bastnaesite Mineralogy at the Rift Rare Earth Project
Published on 08/20/2026 at 23:00, 14 hours 50 minutes ago EQ Inc. Reports Second Quarter 2026 Financial Results
Published on 08/20/2026 at 22:00, 15 hours 50 minutes ago Gold Terra Closes Third and Final Tranche of Its LIFE Offering for Gross Proceeds of Approximately C$10.1 M
Published on 08/21/2026 at 12:27, 1 hour 22 minutes ago Brockhaus Technologies AG: Annual General Meeting approves share buyback of up to €90 million and balance-sheet optimization by a clear majority
Published on 08/21/2026 at 12:05, 1 hour 45 minutes ago METLEN conducts First Fire on Waste at the Protos ERF plant in Cheshire
Published on 08/21/2026 at 11:46, 2 hours 4 minutes ago 2026 Annual General Meeting: Three Pillars – One Strategy
Published on 08/21/2026 at 11:28, 2 hours 22 minutes ago EQS-Adhoc: Borussia Dortmund GmbH & Co. KGaA: Borussia Dortmund publishes preliminary figures for the 2025/2026 financial year
Published on 08/21/2026 at 11:28, 2 hours 22 minutes ago Circus Holds Successful 2026 Annual General Meeting as Global AI Robotics Rollout Progresses
Published on 08/18/2026 at 18:00, 2 days 19 hours ago KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 2 days 20 hours ago Mise à disposition du rapport financier annuel 2025-26
Published on 08/18/2026 at 11:15, 3 days 2 hours ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026
